What is Esperion Therapeutics's compensation and benefits?

Esperion Therapeutics (ESPR) reported compensation and benefits of $6.94M in Q1 2026.

How has Esperion Therapeutics's compensation and benefits changed year-over-year?

Esperion Therapeutics's compensation and benefits increased by 8.1% year-over-year, from $6.42M to $6.94M.

What is the long-term trend for Esperion Therapeutics's compensation and benefits?

Over 5 years (2020 to 2025), Esperion Therapeutics's compensation and benefits has grown at a -4.7% compound annual growth rate (CAGR), from $15.16M to $11.94M.

Esperion Therapeutics ESPR Compensation and benefits

Compensation and benefits at other companies

Lexicon PharmaceuticalsLXRX

——

Nurix Therapeutics, Inc.NRIX

——

BridgeBio PharmaBBIO

——

ViatrisVTRS

——

Nektar TherapeuticsNKTR

——

Avalo TherapeuticsAVTX

——

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's compensation and benefits?: Esperion Therapeutics (ESPR) reported compensation and benefits of $6.94M in Q1 2026.
How has Esperion Therapeutics's compensation and benefits changed year-over-year?: Esperion Therapeutics's compensation and benefits increased by 8.1% year-over-year, from $6.42M to $6.94M.
What is the long-term trend for Esperion Therapeutics's compensation and benefits?: Over 5 years (2020 to 2025), Esperion Therapeutics's compensation and benefits has grown at a -4.7% compound annual growth rate (CAGR), from $15.16M to $11.94M.